Skip to main content
Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
0.785
+0.005 (0.69%)
At close: Mar 9, 2026, 4:00 PM EDT
0.780
-0.005 (-0.69%)
After-hours: Mar 9, 2026, 4:00 PM EDT

Gelteq Revenue

In the fiscal year ending June 30, 2025, Gelteq had annual revenue of 413.13K AUD with 188.27% growth. Gelteq had revenue of 101.72K in the half year ending June 30, 2025.

Revenue (ttm)
413.13K AUD
Revenue Growth
+188.27%
P/S Ratio
29.34
Revenue / Employee
51,642 AUD
Employees
8
Market Cap
8.41M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025413.13K269.82K188.27%
Jun 30, 2024143.31K-199.59K-58.21%
Jun 30, 2023342.90K-29.17K-7.84%
Jun 30, 2022372.07K212.20K132.73%
Jun 30, 2021159.87K--
Jun 30, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 37.61M
Sunshine Biopharma 37.32M
Biofrontera 37.16M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
RedHill Biopharma 9.55M
InMed Pharmaceuticals 4.51M
China Pharma Holdings 4.05M
Revenue Rankings

GELS News

More News